MENU
CNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Context Therapeutics (CNTX) Earnings Date & Reports
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more
A.I. Advisor
published Earnings
CNTX is expected to report earnings to fall 33.33% to -10 cents per share on November 11
Q3'26
Est.
$-0.10
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.02
Q4'25
Missed
by $0.04
Q3'25
Missed
by $0.01
The last earnings report on August 05 showed earnings per share of -15 cents, missing the estimate of -9 cents. With 522.77K shares outstanding, the current market capitalization sits at 21.90M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
2001 Market Street
Phone
+1 267 225-7416
Employees
15
Web
https://www.contexttherapeutics.com